Genetically decreased vitamin D and risk of Alzheimer disease.
Mokry, LE., et al.
2016,  
Annals of clinical and translational neurology
Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases.
Gagliano, SA., et al.
2016,  
European journal of human genetics : EJHG
SORL1 variants across Alzheimer's disease European American cohorts.
Fernández, MV., et al.
2016,  
Nature neuroscience
Novel genetic loci underlying human intracranial volume identified through genome-wide association.
Adams, HHH., et al.
2016,  
Translational psychiatry
Molecular genetic aetiology of general cognitive function is enriched in evolutionarily conserved regions.
Hill, WD., et al.
2016,  
Molecular and cellular probes
Genomics of Alzheimer's disease: Value of high-throughput genomic technologies to dissect its etiology.
Tosto, G.
2016,  
Neurology. Genetics
SORL1 mutations in early- and late-onset Alzheimer disease.
Cuccaro, ML., et al.
2016,  
Acta neuropathologica
Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging.
Nelson, PT., et al.
2016,  
Molecular psychiatry
Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
Herold, C., et al.
2016,  
BMC systems biology
DGCA: A comprehensive R package for Differential Gene Correlation Analysis.
McKenzie, AT., et al.
2016,  
BMC neurology
Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.
Deming, Y., et al.
2016,  
Neurobiology of aging
ABCA7 p.G215S as potential protective factor for Alzheimer's disease.
Sassi, C., et al.
2016,  
JAMA neurology
The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease.
Tosto, G., et al.
2016,  
Molecular psychiatry
Assessing the genetic overlap between BMI and cognitive function.
Marioni, RE., et al.
2016,  
PLoS genetics
Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease.
Jakobsdottir, J., et al.
2016,  
Annals of clinical and translational neurology
Age-dependent effects of APOE ε4 in preclinical Alzheimer's disease.
Bonham, LW., et al.
2016,  
Nature genetics
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.
Kenna, KP., et al.
2016,  
Neurology
Incident parkinsonism in older adults without Parkinson disease.
Buchman, AS., et al.
2016,  
Molecular neurobiology
PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses.
Zhang, D., et al.
2016,  
Journal of neurology, neurosurgery, and psychiatry
Traumatic brain injury history is associated with earlier age of onset of frontotemporal dementia.
LoBue, C., et al.
2016,  
Biological psychiatry
Genetic Markers of Human Evolution Are Enriched in Schizophrenia.
Srinivasan, S., et al.
2016,  
Acta neuropathologica
Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.
Allen, M., et al.
2016,  
Bioinformatics (Oxford, England)
Pathway analysis by randomization incorporating structure-PARIS: an update.
Butkiewicz, M., et al.
2016,  
Nature genetics
Detection and interpretation of shared genetic influences on 42 human traits.
Pickrell, JK., et al.
2016,  
European journal of human genetics : EJHG
Evaluation of power of the Illumina HumanOmni5M-4v1 BeadChip to detect risk variants for human complex diseases.
Xing, C., et al.
2016,  
The New England journal of medicine
Incidence of Dementia over Three Decades in the Framingham Heart Study.
Satizabal, C., et al.
2016,  
Journal of Alzheimer's disease : JAD
Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study.
Camargo, EC., et al.
2016,  
BMC genomics
Variants in CCL16 are associated with blood plasma and cerebrospinal fluid CCL16 protein levels.
Ebbert, MTW., et al.
2016,  
Journal of Alzheimer's disease : JAD
Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.
Chouraki, V., et al.
2016,  
The Lancet. Neurology
Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies.
2016,  
BMC genomics
Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels.
Staley, LA., et al.
2016,  
BMC genomics
Genome-wide association study of prolactin levels in blood plasma and cerebrospinal fluid.
Staley, LA., et al.
2016,  
Neurology. Genetics
ABCA7 frameshift deletion associated with Alzheimer disease in African Americans.
Cukier, HN., et al.
2016,  
JAMA neurology
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
Risacher, SL., et al.
2016,  
JAMA neurology
Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease.
Yokoyama, JS., et al.
2016,  
Alzheimer's & dementia : the journal of the Alzheimer's Association
Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.
Allen, GI., et al.
2016,  
Science translational medicine
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.
Scott, RA., et al.
2016,  
BMC bioinformatics
A comprehensive database of high-throughput sequencing-based RNA secondary structure probing data (Structure Surfer).
Berkowitz, ND., et al.
2016,  
Neurobiology of aging
Assessment of the genetic variance of late-onset Alzheimer's disease.
Ridge, PG., et al.
2016,  
Neurobiology of aging
The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable.
Mez, J., et al.
2016,  
Genome medicine
Identification of the BRD1 interaction network and its impact on mental disorder risk.
Fryland, T., et al.
2016,  
Stroke
Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia.
Pase, MP., et al.
2016,  
Neurobiology of aging
The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume.
Lupton, MK., et al.
2016,  
Alzheimer's & dementia : the journal of the Alzheimer's Association
Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk.
Hohman, TJ., et al.
2016,  
Neurology
Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies.
White, LR., et al.
2016,  
Annals of translational medicine
Toward precision medicine in Alzheimer's disease.
Reitz, C.
2016,  
European journal of neurology
Interleukin-6, interleukin-6 receptor gene variant, small-vessel disease and incident dementia.
Miwa, K., et al.
2016,  
Neurology
Low-frequency and common genetic variation in ischemic stroke: The METASTROKE collaboration.
Malik, R., et al.
2016,  
PLoS genetics
Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.
Choi, SH., et al.
2016,  
The New England journal of medicine
Incidence of Dementia over Three Decades in the Framingham Heart Study.
Satizabal, CL., et al.
2016,  
Neurology. Genetics
Segregation of a rare TTC3 variant in an extended family with late-onset Alzheimer disease.
Kohli, MA., et al.
2016,  
Stroke
Genome-Wide Association Analysis of Young-Onset Stroke Identifies a Locus on Chromosome 10q25 Near HABP2.
Cheng, Y., et al.
2016,  
BMC genetics
Family-based approaches: design, imputation, analysis, and beyond.
Wijsman, EM.
2016,  
Neurobiology of aging
Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium.
Hohman, TJ., et al.
2016,  
Alzheimer's & dementia : the journal of the Alzheimer's Association
Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.
Ebbert, MTW., et al.
2016,  
Molecular psychiatry
GWAS for executive function and processing speed suggests involvement of the CADM2 gene.
Ibrahim-Verbaas, CA., et al.
2016,  
Alzheimer's & dementia (Amsterdam, Netherlands)
Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke.
Weinstein, G., et al.
2016,  
BMC proceedings
Estimating relationships between phenotypes and subjects drawn from admixed families.
Blue, EM., et al.
2016,  
BMC proceedings
Identity-by-descent estimation with population- and pedigree-based imputation in admixed family data.
Saad, M., et al.
2016,  
PloS one
Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer's Disease.
Sassi, C., et al.
2016,  
PloS one
Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.
Karch, CM., et al.
2016,  
Journal of Alzheimer's disease : JAD
Self-Reported Traumatic Brain Injury and Mild Cognitive Impairment: Increased Risk and Earlier Age of Diagnosis.
LoBue, C., et al.
2016,  
Alzheimer disease and associated disorders
Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study.
Walter, S., et al.
2016,  
Current protocols in human genetics
In Silico Functional Annotation of Genomic Variation.
Butkiewicz, M.
2016,  
Alzheimer's & dementia : the journal of the Alzheimer's Association
Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.
Kunkle, BW., et al.
2016,  
Molecular psychiatry
A novel Alzheimer disease locus located near the gene encoding tau protein.
Jun, G., et al.
2016,  
Scientific reports
Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits.
Deming, Y., et al.
2016,  
Nucleic acids research
DASHR: database of small human noncoding RNAs.
Leung, YY., et al.
2016,  
Neurobiology of aging
A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.